Peripheral Arterial Insufficiency

Takeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd American Society of Hematology (ASH) Annual Meeting    Galveston County Daily News

Cytosorbents Corp (CTSO) Q2 2020 Earnings Call Transcript    Motley Fool

Sugar Filled Drinks Can Increase the Risk of Heart Diseases    https://ift.tt/1gchDt0

Angiotensin Drugs and COVID-19: More Reassuring Data    Medscape

Angiotensin Drugs and COVID-19: More Reassuring Data    dineshr

Diffusion Pharmaceuticals Evaluating TSC Against Acute Respiratory Distress Syndrome (ARDS) in COVID-19 PatientsPartnering with University of Virginia Health and iTHRIV    BioSpace

VOYAGER PAD: Rivaroxaban Reduces Risk in Symptomatic PAD Post Intervention    Cath Lab Digest

Landmark Phase 3 Study of Xarelto Plus Aspirin Shows Significant Benefit in Patients with Symptomatic PAD after Lower-Extremity Revascularization    PharmaLive

ACC.2020/WCC – COMPASS: Rivaroxaban Reduces CV Events in Atherosclerosis Patients With, Without Diabetes    Cath Lab Digest

Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization | Small Molecules | News Channels    PipelineReview.com

Rivaroxaban Plus Aspirin Safely Benefits PAD Patients After Limb Revascularization    Medscape

ACC House Call: COMPASS Diabetes Insights with Deepak Bhatt, MD    MD Magazine

Diffusion Pharmaceuticals Evaluating TSC Against Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients    StreetInsider.com

VOYAGER PAD: Rivaroxaban Reduces Risk in Symptomatic PAD Post Intervention    Cath Lab Digest

ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer    BioSpace

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease    News-Medical.Net

ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer    Yahoo Finance

Landmark Phase 3 Study of Xarelto Plus Aspirin Shows Significant Benefit in Patients with Symptomatic PAD after Lower-Extremity Revascularization    PharmaLive

ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer    Yahoo Finance

ACC House Call: COMPASS Diabetes Insights with Deepak Bhatt, MD    MD Magazine